ALLMedicine™ Rhegmatogenous Retinal Detachment Center

Research & Reviews 785 results

Rhegmatogenous Retinal Detachment (RRD)
http://emedicine.medscape.com/article/1224737-overview

Mar 14th, 2023 - Background Retinal detachment occurs when subretinal fluid accumulates in the potential space between the neurosensory retina and the underlying retinal pigment epithelium (RPE). Depending on the mechanism of subretinal fluid accumulation, retinal...

Rhegmatogenous Retinal Detachment (RRD)
https://emedicine.medscape.com/article/1224737-print

Tractional Retinal Detachment
http://emedicine.medscape.com/article/1224891-overview

Mar 14th, 2023 - Background Anytime subretinal fluid accumulates in the space between the neurosensory retina and the underlying retinal pigment epithelium (RPE), a retinal detachment occurs. Depending on the mechanism of subretinal fluid accumulation, retinal det...

Tractional Retinal Detachment
https://emedicine.medscape.com/article/1224891-print

Tractional Retinal Detachment
https://emedicine.medscape.com/article/1224891-overview

see more →

Clinicaltrials.gov 58 results

Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy
https://clinicaltrials.gov/ct2/show/NCT05523869

Mar 2nd, 2023 - Intravitreal topotecan has anti-inflammatory, anti-proliferative and anti-fibrotic activity that we hypothesize may exhibit high efficacy for the treatment of proliferative vitreoretinopathy (PVR) in patients with rhegmatogenous retinal detachment...

Assessment of Retinal Vascular Changes With and Without ILM Peeling in Diabetic Vitrectomy Using OCT-A.
https://clinicaltrials.gov/ct2/show/NCT05739539

Feb 22nd, 2023 - Background and Rationale: Diabetic retinopathy (DR) is a leading cause of blindness among the working age group with increasing numbers of persons being affected worldwide. The microvascular complications of diabetes result in macular leakage or e...

A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment
https://clinicaltrials.gov/ct2/show/NCT05730218

Feb 16th, 2023 - The goal of this Phase 2 clinical trial is to learn about ONL1204 Ophthalmic Solution in terms of safety and how well the drug works in patients that have a macula-off (central point of vision) rhegmatogenous retinal detachment (RRD). The main que...

Intravitreal Infliximab for Proliferative Vitreoretinopathy
https://clinicaltrials.gov/ct2/show/NCT04891991

Feb 16th, 2023 - Proliferative vitreoretinopathy (PVR) is the most common cause for failure of rhegmatogenous retinal detachment repair and is characterized by the growth and contraction of cellular membranes within the vitreous cavity on both sides of the retinal...

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
https://clinicaltrials.gov/ct2/show/NCT05660447

Dec 21st, 2022 - The purpose of this study is to determine if a drug called netarsudil is safe and able to prevent the development of scar tissue after retinal detachment repair. Patients eligible for this study are those diagnosed with a rhegmatogenous retinal de...

see more →

News 2 results

Increase in Myopia Mirrors Rise in Retinal Detachment
https://www.medscape.com/viewarticle/942227

Dec 9th, 2020 - NEW YORK (Reuters Health) - Both myopia and rhegmatogenous retinal detachment (RRD) are increasing in the Netherlands and may be related, according to a nationwide study. In a paper in JAMA Ophthalmology, Dr. Redmer van Leeuwen of University Medic...

Angiogenesis Inhibitor Works in Macular Edema
https://www.medpagetoday.com/ophthalmology/generalophthalmology/16301

Oct 6th, 2009 - Action Points Explain to patients that treatment with a drug that inhibits blood vessel growth showed potential for treatment of macular edema caused by retinal vein occlusion. Patients with macular edema related to retinal vein occlusion had sign...

see more →